SEC restatements
Cogent Biosciences, Inc. (COGT)
Cogent Biosciences, Inc. has 2 revised figures in later SEC filings: annual figures whose value in a later filing differs from the value on record first. Each revision below links to both filings.
CIK 0001622229
Most recent revisions
Newest 2 of 2 · as filed · by the latest filing stating each revision
| Figure | On record first | Revised |
|---|---|---|
| Depreciation & amortizationPeriod ended Dec 31, 2023 | $2.27MFiled Feb 26, 2024 (opens EDGAR in a new tab) | $2.30MFiled Feb 17, 2026 (opens EDGAR in a new tab) |
| Net incomePeriod ended Dec 31, 2017 | $25.50MFiled May 14, 2018 (opens EDGAR in a new tab) | $-25.49MFiled Mar 28, 2019 (opens EDGAR in a new tab) |
A revised figure is not by itself a correction of an error. Companies re-present prior figures for ordinary reasons too, such as a discontinued business, a merger or a new accounting standard. The value on record first is the earliest filing we hold that states the figure; the revised value is the latest revised value on record, linked to the latest filing that states it.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- Every revised figure for this company, with both values and both filings (Analyst)
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/revisions/COGT
MCP tool:
get_revisions ticker=COGT
Not investment advice. Figures are shown as filed with the SEC; each one links to the filing it came from.